Heartflow raises $364M with IPO, rings Nasdaq opening bell

Heartflow president and CEO John Farquhar celebrate the company's IPO by ringing Nasdaq's the ceremonial opening bell.

Heartflow President and CEO John Farquhar and other employees ring Nasdaq's ceremonial opening bell. Image courtesy of Nasdaq. Click here for more details.

Heartflow has officially gone public after selling more than 19 million shares of common stock during an upsized IPO. The California medtech company, known for its AI-powered CCTA evaluations, is now being traded on Nasdaq under the symbol HTFL.

Pericarditis: New guidance takes on the diagnosis and management of a challenging heart condition

Pericardial Effusion Sizing Evaluation by Echocardiography. Representative (A) small, (B) moderate, and (C) large PEffs (∗). Representative (D) simple PEff with fibrin strands, (E) exudative PEff, and (F) malignant PEff (∗) caused by pericardial mesothelioma. Adapted with permission from Klein et al. Images and caption courtesy of the American College of Cardiology and JACC.pericarditis cardiac imaging

Pericardial Effusion Sizing Evaluation by Echocardiography. Representative (A) small, (B) moderate, and (C) large PEffs (∗). Representative (D) simple PEff with fibrin strands, (E) exudative PEff, and (F) malignant PEff (∗) caused by pericardial mesothelioma. Adapted with permission from Klein et al. Images and caption courtesy of the American College of Cardiology and JACC.

Pericarditis, inflammation of the pericardium, accounts for approximately 5% of all emergency department evaluations for chest pain. These new recommendations are designed to help guide clinicians through the ins and outs of patient care.